PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA

This adverse event was reported 96 times

These drugs are most commonly taken by patients reporting PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA:

# Drug Count
0 PREDNISONE 57
1 TACROLIMUS 43
2 TACROLIMUS EXTENDED-RELEASE CAPSULES 43
3 TACROLIMUS OINTMENT 0.1% 43
4 DASATINIB 27
5 MYCOPHENOLATE MOFETIL 19
6 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 19
7 NILOTINIB 17
8 IMATINIB 16
9 MESALAMINE 15
See all common drugs associated with PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA

PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DASATINIB 27 0.0029
1 ASCIMINIB 4 0.0011
2 URSOSIOL 15 0.0008
3 URSODIOL 15 0.0007
4 SIROLIMUS 9 0.0007
5 NILOTINIB 17 0.0006
6 MESALAMINE 15 0.0005
7 BETAMETHASONE VALERATE FOAM 2 0.0004
8 TACROLIMUS OINTMENT 0.1% 43 0.0003
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 43 0.0003
See all drugs enriched for association with PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA